OptimizeRx
OPRX
$10.12
Share price
15.00%
Change (1 day)
-32.67%
Change (1 year)
Categories
P/S ratio for OptimizeRx (OPRX)
P/S ratio as of April 2024 (TTM): 2.57
According to OptimizeRx's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.57295. At the end of 2023 the company had a P/S ratio of 2.06.
P/S ratio history for OptimizeRx from 2009 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 2.06 | -55.34% |
| 2022 | 4.61 | -74.37% |
| 2021 | 18.0 | 65.66% |
| 2020 | 10.9 | 78.84% |
| 2019 | 6.08 | -2.21% |
| 2018 | 6.21 | 63.99% |
| 2017 | 3.79 | 22.23% |
| 2016 | 3.10 | -36.79% |
| 2015 | 4.91 | 21.34% |
| 2014 | 4.04 | -20.21% |
| 2013 | 5.07 | -31.2% |
| 2012 | 7.36 | -35.2% |
| 2011 | 11.4 | -92.76% |
| 2010 | 157 | -82.51% |
| 2009 | 898 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Park City Group
PCYG | 9.16 | 256.14% | 🇺🇸 USA |
 LivePerson LPSN | 0.1153 | -95.52% | 🇺🇸 USA |
 Brightcove BCOV | 0.3598 | -86.02% | 🇺🇸 USA |